Diurnal rhythm of plasma catecholamines in acromegaly
- PMID: 10404821
- DOI: 10.1210/jcem.84.7.5867
Diurnal rhythm of plasma catecholamines in acromegaly
Abstract
We investigated the 24-h profiles of the circulating levels of norepinephrine (NE) and epinephrine (E), blood pressure (BP), and heart rate in 14 acromegalic patients, before (A) and 3-6 months after transsphenoidal surgery (C-A, cured; A-A, active), and in 8 age-matched normal subjects (N). In addition, the responses of NE, E, PRA, and aldosterone to upright posture were investigated. No significant differences in the mean 24-h plasma NE and E levels were observed between either group of acromegalics and the N subjects. Analysis of the 24-h profiles indicated a statistically significant 24-h rhythm of both NE and E in N subjects. No evidence of a 24-h rhythm of plasma NE and E and BP was found in A patients. After surgery, a statistically significant 24-h rhythm of NE was detected in the patients with acrophase (13.54 and 13.45 h in C-A and A-A patients, respectively) and mesor (1019.8+/-45.1 and 1017.8+/-54.7 pmol/L in C-A and A-A patients, respectively) similar to those observed in N subjects (acrophase, 13.21 h; mesor, 942.3+/-42.5 pmol/L). After surgery, the plasma concentration of E clearly fluctuated throughout the 24 h in both C-A and A-A patients, even if cosinor analysis failed to reveal a 24-h significant rhythm. A statistically significant 24-h rhythm of BP was restored only in C-A patients. The mean 24-h heart rate was slightly, but significantly (P<0.05), higher in A than in N subjects and decreased after surgery. No significant differences in upright-stimulated NE, E, and plasma aldosterone levels were observed between each group of acromegalics and N subjects. However, basal and upright-stimulated PRA levels were significantly (P<0.001) lower in A patients. In conclusion, our study demonstrates the lack of a clear circadian variation in catecholamine levels and BP in active acromegaly and the return of a significant 24-h rhythm of NE and BP after pituitary surgery, concomitant with the reduction in GH and insulin-like growth factor I serum levels.
Similar articles
-
Plasma norepinephrine and epinephrine in acromegaly.J Clin Endocrinol Metab. 1975 Sep;41(3):542-5. doi: 10.1210/jcem-41-3-542. J Clin Endocrinol Metab. 1975. PMID: 1159061
-
Baseline and stimulated catecholamine secretion in normotensive patients with active acromegaly: acute effects of continuous octreotide infusion.Eur J Endocrinol. 2000 Feb;142(2):179-86. doi: 10.1530/eje.0.1420179. Eur J Endocrinol. 2000. PMID: 10664528
-
The diurnal rhythm of plasma aldosterone, plasma renin activity, plasma cortisol and serum growth hormone and subnormal responsiveness of aldosterone to angiotensin-II in the patients with normotensive acromegaly.Endocrinol Jpn. 1976 Feb;23(1):75-82. doi: 10.1507/endocrj1954.23.75. Endocrinol Jpn. 1976. PMID: 945156
-
The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.J Clin Endocrinol Metab. 2001 Jan;86(1):259-66. doi: 10.1210/jcem.86.1.7154. J Clin Endocrinol Metab. 2001. PMID: 11232010
-
Twenty-four hour melatonin pattern in acromegaly: effect of acute octreotide administration.J Endocrinol Invest. 1997 Mar;20(3):128-33. doi: 10.1007/BF03346890. J Endocrinol Invest. 1997. PMID: 9186818
Cited by
-
Pathogenesis and prevalence of hypertension in acromegaly.Pituitary. 2001 Sep;4(4):239-49. doi: 10.1023/a:1020798430884. Pituitary. 2001. PMID: 12501974 Review.
-
Positive Relationship Between Precompetitive Sympathetic Predominance and Competitive Performance in Elite Extreme Sports Athletes.Front Sports Act Living. 2021 Aug 23;3:712439. doi: 10.3389/fspor.2021.712439. eCollection 2021. Front Sports Act Living. 2021. PMID: 34498000 Free PMC article.
-
Management of acromegaly: is there a role for primary medical therapy?Rev Endocr Metab Disord. 2008 Mar;9(1):83-94. doi: 10.1007/s11154-007-9061-1. Rev Endocr Metab Disord. 2008. PMID: 18163213 Review.
-
Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?J Endocrinol Invest. 2021 Feb;44(2):209-221. doi: 10.1007/s40618-020-01343-0. Epub 2020 Jul 6. J Endocrinol Invest. 2021. PMID: 32632903 Review.
-
Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study.J Endocrinol Invest. 2002 Dec;25(11):971-6. doi: 10.1007/BF03344070. J Endocrinol Invest. 2002. PMID: 12553557
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials